Literature DB >> 1433332

Meeting highlights: adjuvant therapy for primary breast cancer.

J H Glick1, R D Gelber, A Goldhirsch, H J Senn.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1433332     DOI： 10.1093/jnci/84.19.1479

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  The Role of Chemoendocrine Agents in Postoperative Adjuvant Therapy for Breast Cancer: Meta-analysis of the First Collaborative Studies of Postoperative Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC).

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

2.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

3.  Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401).

Authors:  Tadahiko Shien; Hiroji Iwata; Kenjiro Aogi; Takashi Fukutomi; Kenichi Inoue; Takayuki Kinoshita; Masato Takahashi; Akira Matsui; Taro Shibata; Haruhiko Fukuda
Journal:  Int J Clin Oncol       Date:  2014-01-07       Impact factor: 3.402

4.  Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994.

Authors:  N Hébert-Croteau; J Brisson; J Latreille; C Blanchette; L Deschênes
Journal:  CMAJ       Date:  1999-10-19       Impact factor: 8.262

5.  Breast cancer treatment of older women in integrated health care settings.

Authors:  Shelley M Enger; Soe Soe Thwin; Diana S M Buist; Terry Field; Floyd Frost; Ann M Geiger; Timothy L Lash; Marianne Prout; Marianne Ulcickas Yood; Feifei Wei; Rebecca A Silliman
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

6.  Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis.

Authors:  M Greco; R Agresti; N Cascinelli; P Casalini; R Giovanazzi; A Maucione; G Tomasic; C Ferraris; M Ammatuna; S Pilotti; S Menard
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

7.  Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection.

Authors:  E C Dees; L N Shulman; W W Souba; B L Smith
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

8.  A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.

Authors:  Jaclyn L F Bosco; Rebecca A Silliman; Soe Soe Thwin; Ann M Geiger; Diana S M Buist; Marianne N Prout; Marianne Ulcickas Yood; Reina Haque; Feifei Wei; Timothy L Lash
Journal:  J Clin Epidemiol       Date:  2009-05-19       Impact factor: 6.437

9.  Breast cancer recurrence in older women five to ten years after diagnosis.

Authors:  Jaclyn L F Bosco; Timothy L Lash; Marianne N Prout; Diana S M Buist; Ann M Geiger; Reina Haque; Feifei Wei; Rebecca A Silliman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

10.  Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients.

Authors:  Masujiro Makita; Takehiko Sakai; Akemi Kataoka; Dai Kitagawa; Akiko Ogiya; Hidetomo Morizono; Yumi Miyagi; Kotaro Iijima; Kokoro Kobayashi; Takayuki Kobayashi; Ippei Fukada; Kazuhiro Araki; Shunji Takahashi; Yoshinori Ito; Naoya Gomi; Masahiko Oguchi; Mizuho Kita; Masami Arai; Futoshi Akiyama; Takuji Iwase
Journal:  Springerplus       Date:  2015-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.